News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,449 Results
Type
Article (44843)
Company Profile (270)
Press Release (692326)
Multimedia
Podcasts (91)
Webinars (17)
Section
Business (207079)
Career Advice (2158)
Deals (35883)
Drug Delivery (122)
Drug Development (82947)
Employer Resources (175)
FDA (16637)
Job Trends (15242)
News (351314)
Policy (33415)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2664)
Accelerated approval (33)
Adcomms (25)
Allergies (146)
Alliances (50190)
ALS (174)
Alzheimer's disease (1678)
Antibody-drug conjugate (ADC) (316)
Approvals (16894)
Artificial intelligence (518)
Autoimmune disease (156)
Automation (39)
Bankruptcy (366)
Best Places to Work (11856)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (175)
Bladder cancer (160)
Brain cancer (59)
Breast cancer (641)
Cancer (4856)
Cardiovascular disease (407)
Career advice (1817)
Career pathing (36)
CAR-T (290)
CDC (51)
Celiac Disease (2)
Cell therapy (760)
Cervical cancer (37)
Clinical research (70723)
Collaboration (1712)
Company closure (4)
Compensation (1162)
Complete response letters (57)
COVID-19 (2775)
CRISPR (91)
C-suite (846)
Cystic fibrosis (145)
Data (6260)
Decentralized trials (2)
Denatured (26)
Depression (136)
Diabetes (508)
Diagnostics (6785)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (256)
Drug pricing (202)
Drug shortages (29)
Duchenne muscular dystrophy (233)
Earnings (90558)
Editorial (62)
Employer branding (22)
Employer resources (154)
Events (120204)
Executive appointments (982)
FDA (19765)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1479)
Gene editing (201)
Generative AI (43)
Gene therapy (610)
GLP-1 (1004)
Government (4819)
Grass and pollen (6)
Guidances (383)
Healthcare (19365)
HIV (59)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (254)
Immuno-oncology (58)
Indications (110)
Infectious disease (3049)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (251)
Interviews (332)
IPO (16762)
IRA (53)
Job creations (3720)
Job search strategy (1528)
JPM (58)
Kidney cancer (16)
Labor market (86)
Layoffs (557)
Leadership (31)
Legal (8107)
Liver cancer (91)
Longevity (14)
Lung cancer (654)
Lymphoma (379)
Machine learning (42)
Management (60)
Manufacturing (802)
MASH (166)
Medical device (13933)
Medtech (13986)
Mergers & acquisitions (20192)
Metabolic disorders (1296)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (317)
Neuropsychiatric disorders (90)
Neuroscience (2927)
Neurotech (1)
NextGen: Class of 2026 (6740)
Non-profit (4734)
Now hiring (67)
Obesity (612)
Opinion (271)
Ovarian cancer (167)
Pain (200)
Pancreatic cancer (227)
Parkinson's disease (283)
Partnered (33)
Patents (496)
Patient recruitment (491)
Peanut (58)
People (59912)
Pharmaceutical (63)
Pharmacy benefit managers (31)
Phase 1 (22001)
Phase 2 (31075)
Phase 3 (23200)
Pipeline (5294)
Policy (303)
Postmarket research (2704)
Preclinical (9413)
Press Release (65)
Prostate cancer (241)
Psychedelics (48)
Radiopharmaceuticals (286)
Rare diseases (848)
Real estate (6092)
Recruiting (70)
Regulatory (24916)
Reports (52)
Research institute (2453)
Resumes & cover letters (372)
Rett syndrome (27)
RNA editing (17)
RSV (78)
Schizophrenia (150)
Series A (242)
Series B (191)
Service/supplier (11)
Sickle cell disease (101)
Special edition (23)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3653)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (89)
The Weekly (63)
Vaccines (1036)
Venture capital (89)
Weight loss (397)
Women's health (91)
Worklife (19)
Date
Today (21)
Last 7 days (588)
Last 30 days (2024)
Last 365 days (30063)
2026 (3466)
2025 (30463)
2024 (35570)
2023 (40466)
2022 (51608)
2021 (56205)
2020 (54845)
2019 (47590)
2018 (35815)
2017 (32634)
2016 (32251)
2015 (38297)
2014 (32051)
2013 (27197)
2012 (29458)
2011 (30147)
2010 (28495)
Location
Africa (774)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (40053)
Australia (6597)
California (11331)
Canada (3301)
China (1120)
Colorado (478)
Connecticut (477)
Delaware (336)
Europe (86938)
Florida (1694)
Georgia (357)
Hawaii (3)
Idaho (62)
Illinois (876)
India (65)
Indiana (521)
Iowa (23)
Japan (432)
Kansas (128)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1395)
Massachusetts (8165)
Michigan (329)
Minnesota (630)
Mississippi (5)
Missouri (131)
Montana (33)
Nebraska (28)
Nevada (123)
New Hampshire (80)
New Jersey (3018)
New Mexico (29)
New York (2990)
North Carolina (1465)
North Dakota (9)
Northern California (5537)
Ohio (333)
Oklahoma (21)
Oregon (41)
Pennsylvania (2284)
Puerto Rico (24)
Rhode Island (49)
South America (1200)
South Carolina (66)
South Dakota (1)
Southern California (4409)
Tennessee (176)
Texas (1749)
United States (40260)
Utah (337)
Vermont (1)
Virginia (262)
Washington D.C. (82)
Washington State (922)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
737,449 Results for "sysmex america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sysmex America Expands CN™-Series with CN-9000 to Help Labs of All Sizes Optimize Workflow
January 22, 2026
·
2 min read
Press Releases
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
February 5, 2026
·
5 min read
Press Releases
Sysmex America Receives FDA Clearance for Automated Blood Coagulation Analyzer CN-Series CN-6000™
June 26, 2025
·
2 min read
BioMidwest
Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
April 2, 2024
·
2 min read
BioMidwest
Sysmex America Becomes Exclusive Distributor of vermicon VIT® System in Canada, Latin America and Americas
Sysmex America, Inc., a leading diagnostic solutions company, has been named the exclusive distributor of vermicon identification technology System in Canada, Latin America and all the Americas.
December 14, 2023
·
2 min read
Press Releases
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320
March 3, 2025
·
2 min read
Press Releases
Sysmex America Signs Agreement to Distribute and Service Sentinel Diagnostics SENTiFIT® in Canada
January 7, 2025
·
2 min read
Press Releases
Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America
December 2, 2025
·
2 min read
Press Releases
Sysmex Corporation Receives Health Canada License for the CN-3000™ & CN-6000™ Automated Blood Coagulation Analyzers
June 26, 2025
·
1 min read
Business
Sysmex America Announces Dan Zortman as New CEO
July 10, 2024
·
2 min read
1 of 73,745
Next
